For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220106:nRSF5684Xa&default-theme=true
RNS Number : 5684X Deepverge PLC 06 January 2022
6 January 2022
DeepVerge PLC
("DeepVerge" or "Company")
Microtox water testing equipment installed ahead of Beijing 2022 Winter
Olympics
DeepVerge (LSE:DVRG.L), announces that its environmental division, Modern
Water, has completed installation of Microtox(®) Continuous Toxicity Monitor
("CTM") permanent units and Microtox(®) FX portable laboratory units in
Beijing, China, ahead of the athletes arriving at the 2022 Winter Olympics
Village.
Microtox(®) CTM is a site-based, broad range Continuous Toxicity Monitor that
continuously measures the chemical toxicity of a water source, giving instant
indication of water health. It is a fully automatic instrument that offers a
4-week, autonomous operating cycle and requires a low level of skill for both
operation and maintenance.
Microtox(®) FX has a combined detection capability that provides a very
sensitive and rapid test to detect two of the most probable classes of agents,
pathogens and toxic chemicals that may accidentally or intentionally
contaminate drinking water or wastewater. Microtox(®) FX's acute toxicity and
ATP (adenosine triphosphate) detection capabilities make it the ideal
instrument for rapidly and accurately assessing if the quality of drinking
water, from the source to the tap, has been affected by an incident.
Gerard Brandon, CEO of DeepVerge plc, commented:
"Once again, water suppliers to the Olympic Games have placed their trust, and
the safety of athletes and officials, in the hands of Modern Water. The
company's Microtox(®) toxicity testing has been used at every Olympics
competition since Los Angeles 1984, apart from last year's Tokyo Olympics
because of travel restrictions. With the Covid-19 pandemic still affecting
much of the world, the importance of identifying pathogens in water can't be
overstated, which is why Modern Water is working with governments to help
track the virus and even predict where future outbreaks could occur."
DeepVerge plc Gerry Brandon +44 (0) 7340 055 648
SPARK Advisory Partners Limited Neil Baldwin/Andrew Emmott +44 (0) 113 370 8974
(Nominated Adviser)
Turner Pope Investments (TPI) Limited (Broker) Andy Thacker/James Pope +44 (0) 20 3657 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of companies that
develops and applies AI and IoT technology to analytical instruments and the
data they generate, for the analysis and identification of bacteria, virus and
toxins. DeepVerge is utilising artificial intelligent data analytics to prove
scientifically the impact of skincare product claims on the skin microbiome
for clients including most of the top 20 global cosmetic companies and to
detect remotely, and identify in real-time, dangerous pathogens in wastewater
treatment plants, drinking water, rivers, lakes and reservoirs.
About Reach announcements
Reach is an investor communication service aimed at assisting listed and
unlisted (including AIM quoted) companies to distribute media only /
non-regulatory news releases such as marketing messages, corporate and product
information into the public domain. An RNS Regulatory announcement is required
to be notified under the AIM Rules for Companies.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRABAMRTMTIMBRT